News

The company is planning to develop some of its vaccines jointly with its partners from further financing round, which will be concluded by the end of 2011. CAP

Tarceva is a once-daily, oral, non-chemotherapy treatment for the treatment of advanced or metastatic NSCLC. The CHMP positive opinion is based on EURTAC study data that demonstrated Tarceva

As per the terms of the agreement, Bristol-Myers Squibb will take over all of Amira’s issued and outstanding shares of capital stock and stock equivalents. Bristol-Myers Squibb will

RG1068, a synthetic version of the hormone secretin, is known to both stimulate the secretion of pancreatic fluid into the pancreatic ducts and to increase blood flow to

The lawsuit covers Pronova BioPharma’s US patent no 7,732,488, US patent no. 7,678,930 and US patent no. 7,718,698. The patents entitled, ‘Pharmaceutical Composition Comprising Low Concentrations of Environmental

CHMP’s decision was backed by the positive results of a Phase III RADIANT-3 (RAD001 In Advanced Neuroendocrine Tumors) trial which demonstrated that the patients with advanced pancreatic NET

Sublinox, based on Orexo’s sublingual tablet technology is indicated as a short term treatment of insomnia. The tablet is a sublingual orally dissolving tablet that is placed under

A subsidiary of Glenmark Pharmaceuticals Limited India (GPL), GPSA’s GRC 15300 is an inhibitor of the TRPV3 and has demonstrated significant pharmacokinetic profile in the trial. The results

Dutasteride and tamsulosin hydrochloride capsules of Watson Pharma are the generic version of GSK‘s JALYN, which is used to treat symptomatic benign prostatic hyperplasia (BPH) in men suffering